×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
CAI – caris life sciences, inc. (US:NYSE)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
CAI
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
4/17
08:45 am
cai
Caris Precision Oncology Alliance Welcomes UCSF Helen Diller Family Comprehensive Cancer Center [TheStreet.com]
Low
Report
Caris Precision Oncology Alliance Welcomes UCSF Helen Diller Family Comprehensive Cancer Center [TheStreet.com]
4/17
08:30 am
cai
Caris Precision Oncology Alliance Welcomes UCSF Helen Diller Family Comprehensive Cancer Center
Medium
Report
Caris Precision Oncology Alliance Welcomes UCSF Helen Diller Family Comprehensive Cancer Center
4/15
08:50 am
cai
Caris Life Sciences Right-In-Time Clinical Trial Solution Expands Access to Precision Oncology Trials for Historically Underserved Cancer Patients [TheStreet.com]
Medium
Report
Caris Life Sciences Right-In-Time Clinical Trial Solution Expands Access to Precision Oncology Trials for Historically Underserved Cancer Patients [TheStreet.com]
4/15
08:30 am
cai
Caris Life Sciences Right-In-Time Clinical Trial Solution Expands Access to Precision Oncology Trials for Historically Underserved Cancer Patients
Low
Report
Caris Life Sciences Right-In-Time Clinical Trial Solution Expands Access to Precision Oncology Trials for Historically Underserved Cancer Patients
4/13
08:34 am
cai
Caris Life Sciences (CAI) is now covered by Jefferies Financial Group Inc.. They set a "buy" rating and a $28.00 price target on the stock.
Medium
Report
Caris Life Sciences (CAI) is now covered by Jefferies Financial Group Inc.. They set a "buy" rating and a $28.00 price target on the stock.
4/10
08:00 am
cai
Caris Life Sciences (CAI) is now covered by Piper Sandler. They set a "neutral" rating and a $21.00 price target on the stock.
Medium
Report
Caris Life Sciences (CAI) is now covered by Piper Sandler. They set a "neutral" rating and a $21.00 price target on the stock.
4/8
08:13 pm
cai
Caris Life Sciences Introduces Multimodal AI-Powered Molecular Insight to Identify the Benefit or Harm from the Addition of Chemotherapy for NSCLC Patients [Yahoo! Finance]
Medium
Report
Caris Life Sciences Introduces Multimodal AI-Powered Molecular Insight to Identify the Benefit or Harm from the Addition of Chemotherapy for NSCLC Patients [Yahoo! Finance]
4/8
08:52 am
cai
Caris Life Sciences Introduces Multimodal AI-Powered Molecular Insight to Identify the Benefit or Harm from the Addition of Chemotherapy for NSCLC Patients [TheStreet.com]
Low
Report
Caris Life Sciences Introduces Multimodal AI-Powered Molecular Insight to Identify the Benefit or Harm from the Addition of Chemotherapy for NSCLC Patients [TheStreet.com]
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
4/7
01:21 pm
cai
Form SCHEDULE 13G/A Caris Life Sciences, Filed by: FMR LLC
Low
Report
Form SCHEDULE 13G/A Caris Life Sciences, Filed by: FMR LLC
4/2
04:29 pm
cai
Form 8-K Caris Life Sciences, For: Apr 01
Low
Report
Form 8-K Caris Life Sciences, For: Apr 01
3/10
06:01 pm
cai
Form 4 Caris Life Sciences, For: Mar 06 Filed by: Power Luke Thomas
Low
Report
Form 4 Caris Life Sciences, For: Mar 06 Filed by: Power Luke Thomas
3/10
06:00 pm
cai
Form 4 Caris Life Sciences, For: Mar 06 Filed by: Denton John Russel
Low
Report
Form 4 Caris Life Sciences, For: Mar 06 Filed by: Denton John Russel
3/10
06:00 pm
cai
Form 4 Caris Life Sciences, For: Mar 06 Filed by: Spetzler David Baxley
Low
Report
Form 4 Caris Life Sciences, For: Mar 06 Filed by: Spetzler David Baxley
3/10
06:00 pm
cai
Form 4 Caris Life Sciences, For: Mar 06 Filed by: Brille Brian J
Low
Report
Form 4 Caris Life Sciences, For: Mar 06 Filed by: Brille Brian J
3/10
05:56 pm
cai
Form 4 Caris Life Sciences, For: Mar 06 Filed by: HALBERT DAVID D
Low
Report
Form 4 Caris Life Sciences, For: Mar 06 Filed by: HALBERT DAVID D
3/3
04:46 pm
cai
Form 10-K Caris Life Sciences, For: Dec 31
Low
Report
Form 10-K Caris Life Sciences, For: Dec 31
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
3/16
Form 4 CAI International, Inc. For: Mar 02 Filed by: HALLAHAN DANIEL JAMES
10.9%
12/16 CAI International, Inc. Announces Review of Strategic Alternatives 8.6%
4/7 CAI International Inc (NYSE: CAI) was downgraded by analysts at ValuEngine from a "hold" rating to a "sell" rating. 3.9%
4/29 Form 10-K/A CAI International, Inc. For: Dec 31 3.8%
8/23 Form SC 13D CAI International, Inc. Filed by: Weiss Asset Management LP 3.1%
10/21 CAI International Inc (NYSE: CAI) had its "sell" rating re-affirmed by analysts at Wells Fargo & Co. 2.6%
2/3 Form SC 13D/A CAI International, Inc. Filed by: Weiss Asset Management LP 2.5%
8/5 CAI International Inc (NYSE: CAI) was upgraded by analysts at Zacks Investment Research from a "sell" rating to a "hold" rating. 2.5%
10/9 CAI International Inc (NYSE: CAI) was upgraded by analysts at Zacks Investment Research from a "strong sell" rating to a "hold" rating. 2.2%
9/10 Form SC 13G/A CAI International, Inc. Filed by: WELLINGTON MANAGEMENT GROUP LLP 1.8%
12/16 CAI International, Inc. Announces Review of Strategic Alternatives 8.6%
4/7 CAI International Inc (NYSE: CAI) was downgraded by analysts at ValuEngine from a "hold" rating to a "sell" rating. 3.9%
4/29 Form 10-K/A CAI International, Inc. For: Dec 31 3.8%
8/23 Form SC 13D CAI International, Inc. Filed by: Weiss Asset Management LP 3.1%
10/21 CAI International Inc (NYSE: CAI) had its "sell" rating re-affirmed by analysts at Wells Fargo & Co. 2.6%
2/3 Form SC 13D/A CAI International, Inc. Filed by: Weiss Asset Management LP 2.5%
8/5 CAI International Inc (NYSE: CAI) was upgraded by analysts at Zacks Investment Research from a "sell" rating to a "hold" rating. 2.5%
10/9 CAI International Inc (NYSE: CAI) was upgraded by analysts at Zacks Investment Research from a "strong sell" rating to a "hold" rating. 2.2%
9/10 Form SC 13G/A CAI International, Inc. Filed by: WELLINGTON MANAGEMENT GROUP LLP 1.8%
TOP News Decliners
3/16
CAI Logistics’ Flatbed Team Named to Supply & Demand Chain Executive’s 2020 List of Pros to Know
-18.5%
3/11 CAI International Inc (NYSE: CAI) was downgraded by analysts at Zacks Investment Research from a "hold" rating to a "strong sell" rating. -17.1%
8/7 Form 10-Q CAI International, Inc. For: Jun 30 -5.9%
3/4 Form 4 CAI International, Inc. For: Mar 02 Filed by: Cutino Camille -5.8%
2/21 CAI International Inc (NYSE: CAI) was downgraded by analysts at ValuEngine from a "hold" rating to a "sell" rating. -5.7%
3/5 Q4/2019 12/31/2019 EPS 0.540 ZacksConsensus N/A ActVsEst N/A - N/A -3.5%
2/24 Form 4 CAI International, Inc. For: Feb 13 Filed by: PAGE TIMOTHY B -3.4%
5/31 CAI International Inc (NYSE: CAI) was upgraded by analysts at ValuEngine from a "sell" rating to a "hold" rating. -3.3%
10/29 CAI International, Inc. Reports Results for the Third Quarter of 2019 -2.2%
6/21 Form S-8 CAI International, Inc. -1.6%
3/11 CAI International Inc (NYSE: CAI) was downgraded by analysts at Zacks Investment Research from a "hold" rating to a "strong sell" rating. -17.1%
8/7 Form 10-Q CAI International, Inc. For: Jun 30 -5.9%
3/4 Form 4 CAI International, Inc. For: Mar 02 Filed by: Cutino Camille -5.8%
2/21 CAI International Inc (NYSE: CAI) was downgraded by analysts at ValuEngine from a "hold" rating to a "sell" rating. -5.7%
3/5 Q4/2019 12/31/2019 EPS 0.540 ZacksConsensus N/A ActVsEst N/A - N/A -3.5%
2/24 Form 4 CAI International, Inc. For: Feb 13 Filed by: PAGE TIMOTHY B -3.4%
5/31 CAI International Inc (NYSE: CAI) was upgraded by analysts at ValuEngine from a "sell" rating to a "hold" rating. -3.3%
10/29 CAI International, Inc. Reports Results for the Third Quarter of 2019 -2.2%
6/21 Form S-8 CAI International, Inc. -1.6%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: